Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Aust Dent J ; 66(3): 332-336, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33438220

RESUMO

Accidental contact of various chemicals in dentistry may cause damage to the gingiva. A male patient presented for a full mouth rehabilitation with ceramic crowns. The patient underwent the steps of ceramic crown preparation uneventfully. At the time of crown delivery, cotton rolls were placed in several vestibular areas for isolation. They were regularly changed during different steps of etching and cementation process, which included the use of Multilink Primer B (Ivoclar Vivadent™). On removal of the cotton roll in the area of upper right canine, the gingival tissues appeared blanched and grayish white. The cotton roll was found to have absorbed some etching material in it. As the patient was asymptomatic, he was dismissed. Two weeks later, the patient presented with inflammation and gingival recession in the same area. Initially, he was treated palliatively, and subsequently, he received a connective tissue graft on the upper right canine. This case report showed that acid etching material used during the prosthodontic cementation may have caused a gingival recession, which was successfully treated with tunnel flap and connective tissue graft. Optimal isolation of the operative field should be performed to avoid this problem.


Assuntos
Retração Gengival , Cimentação , Coroas , Porcelana Dentária , Gengiva , Retração Gengival/etiologia , Humanos , Doença Iatrogênica , Masculino
2.
Aust Dent J ; 65(1): 100-103, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31769879

RESUMO

Bisphosphonates (BPs) have long been used for the treatment of osteoporosis and diseases like bone malignancies, active Paget's disease of bone, severe osteogenesis imperfecta and fibrous dysplasia among others. They bond highly to the bone surface and inhibit bone resorption. As BPs have a long half-life in bone because of their irreversible binding to bone, patients retain their risk profile even after drug cessation. This property also explains the complications wherein the cessation of bone resorption leads to halt in bone turnover. Usually with alendronate the risk of bisphosphonate-related osteonecrosis of jaw (BRONJ) wears off after 12 months. Reporting of the development of BRONJ is commonly associated with the intravenous BPs. Invasive surgical procedure associated with the placement of implants has been shown to be a major reason for the occurrence or initiation of BRONJ in susceptible patients. The prognosis of implants placed in the jaws of patients under or past BP medication is still uncertain. The present case report describes a patient on long-term oral BP therapy with spontaneous exfoliation of implant supported bone due to osteonecrosis.


Assuntos
Osteonecrose da Arcada Osseodentária Associada a Difosfonatos/etiologia , Conservadores da Densidade Óssea/efeitos adversos , Implantes Dentários/efeitos adversos , Osteonecrose/induzido quimicamente , Alendronato/efeitos adversos , Difosfonatos/efeitos adversos , Humanos
3.
J Periodontal Res ; 47(3): 320-9, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22092062

RESUMO

BACKGROUND AND OBJECTIVE: Marijuana (Cannabis sativa) use may be associated with gingival enlargement, resembling that caused by phenytoin. Cannabidiol (CBD), a nonpsychotropic Cannabis derivative, is structurally similar to phenytoin. While there are many reports on effects of phenytoin on human gingival fibroblasts, there is no information on effects of Cannabis components on these cells. The objective of this study was to determine effects of CBD on human gingival fibroblast fibrogenic and matrix-degrading activities. MATERIAL AND METHODS: Fibroblasts were incubated with CBD in serum-free medium for 1-6 d. The effect of CBD on cell viability was determined by measuring activity of a mitochondrial enzyme. The fibrogenic molecule transforming growth factor ß and the extracellular matrix molecule fibronectin were measured by ELISA. Pro-MMP-1 and total MMP-2 were measured by ELISA. Activity of MMP-2 was determined via a colorimetric assay in which a detection enzyme is activated by active MMP-2. Data were analysed using ANOVA and Scheffe's F procedure for post hoc comparisons. RESULTS: Cannabidiol had little or no significant effect on cell viability. Low CBD concentrations increased transforming growth factor ß production by as much as 40% (p < 0.001), while higher concentrations decreased it by as much as 40% (p < 0.0001). Cannabidiol increased fibronectin production by as much as approximately 100% (p < 0.001). Lower CBD concentrations increased MMP production, but the highest concentrations decreased production of both MMPs (p < 0.05) and decreased MMP-2 activity (p < 0.02). CONCLUSION: The data suggest that the CBD may promote fibrotic gingival enlargement by increasing gingival fibroblast production of transforming growth factor ß and fibronectin, while decreasing MMP production and activity.


Assuntos
Canabidiol/farmacologia , Matriz Extracelular/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Fibronectinas/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Metaloproteinases da Matriz/efeitos dos fármacos , Fator de Crescimento Transformador beta/efeitos dos fármacos , Canabidiol/toxicidade , Técnicas de Cultura de Células , Sobrevivência Celular/efeitos dos fármacos , Meios de Cultura Livres de Soro , Precursores Enzimáticos/biossíntese , Precursores Enzimáticos/efeitos dos fármacos , Matriz Extracelular/enzimologia , Fibromatose Gengival/fisiopatologia , Fibronectinas/biossíntese , Gelatinases/biossíntese , Gelatinases/efeitos dos fármacos , Gengiva/citologia , Humanos , Metaloproteinase 1 da Matriz/biossíntese , Metaloproteinase 1 da Matriz/efeitos dos fármacos , Metaloproteinase 2 da Matriz/biossíntese , Metaloproteinase 2 da Matriz/efeitos dos fármacos , Fatores de Tempo , Fator de Crescimento Transformador beta/biossíntese
4.
J Periodontal Res ; 46(4): 483-90, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21463327

RESUMO

BACKGROUND AND OBJECTIVE: Three-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase competitive inhibitors, or 'statins', are widely used for lowering cholesterol and thereby reducing the risk of a heart attack. Recent data suggest that statins influence metabolic bone activity by their actions on three molecules: RANKL; RANK; and osteoprotegerin (OPG), the soluble decoy receptor for RANKL. The purpose of this study was to evaluate OPG and RANKL production in resting and interleukin-1ß (IL-1ß)-activated human gingival fibroblasts (HGFs), and to determine the effect of statins on their production. MATERIAL AND METHODS: Fibroblasts were pre-incubated with atorvastatin or simvastatin for 24h in serum-free medium, and then incubated with IL-1ß for 6d. The concentration of OPG or RANKL in culture supernatants was measured by specific ELISA. Data were analyzed using analysis of variance and Scheffe's F procedure for post hoc comparison. RESULTS: IL-1ß (1×10(-8) m) stimulated a significant increase in the production of OPG on days 1, 3 and 6. There was a trend towards an increase in RANKL production as a result of stimulation with IL-1ß. Both statins, at multiple concentrations, significantly increased the constitutive RANKL/OPG ratio. Only atorvastatin at the highest concentration (5×10(-6) m) significantly increased the IL-1ß-stimulated RANKL/OPG ratio. CONCLUSION: IL-1ß significantly increased OPG production by HGFs. The statins differed minimally in their effects on OPG and RANKL production by resting and IL-1ß-activated HGFs. Both statins increased constitutive RANKL/OPG ratios, but generally not IL-1ß-stimulated ratios. Thus, statins may influence the production of RANKL and OPG by HGFs to favor bone catabolism, under noninflammatory conditions.


Assuntos
Fibroblastos/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia , Interleucina-1beta/farmacologia , Osteoprotegerina/efeitos dos fármacos , Ligante RANK/efeitos dos fármacos , Atorvastatina , Técnicas de Cultura de Células , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Corantes , Meios de Cultura Livres de Soro , Gengiva/citologia , Ácidos Heptanoicos/farmacologia , Ácidos Heptanoicos/toxicidade , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/toxicidade , Osteoprotegerina/análise , Pirróis/farmacologia , Pirróis/toxicidade , Ligante RANK/análise , Sinvastatina/farmacologia , Sinvastatina/toxicidade , Temperatura , Sais de Tetrazólio , Tiazóis , Fatores de Tempo
5.
Clin Exp Dermatol ; 34(3): 333-6, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19040523

RESUMO

Multinucleate cell angiohistiocytoma (MCAH) is an uncommon benign soft-tissue lesion with characteristic histological and immunohistochemical features. It is unclear if it represents a benign neoplasm or a reactive/inflammatory process. The overwhelming majority of these tumors have been described on cutaneous surfaces. One case has been reported on the skin of the lip. This is the first documentation of MCAH within the oral cavity. The clinical presentation, histopathological features and immunohistochemical reactivity pattern are described. Because of the benign nature of this lesion, a conservative approach is recommended in its management. Surgical excision appears to be curative.


Assuntos
Histiocitoma/patologia , Neoplasias Bucais/patologia , Adulto , Núcleo Celular/patologia , Células Dendríticas/patologia , Cárie Dentária/complicações , Histiocitoma/etiologia , Humanos , Masculino , Mucosa Bucal/patologia , Neoplasias Bucais/etiologia
7.
West Indian Med J ; 50(2): 105-8, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11677904

RESUMO

The tetracyclines are a group of broad-spectrum antimicrobial agents. The first of these compounds, chlortetracycline was isolated from Streptomyces aureofaciens by Benjamin Duggar and introduced into the market in 1948. In 1952, tetracycline was derived semisynthetically from chlortetracycline by removal of its chlorine atom by catalytic hydrogenation. Methacycline, doxycycline and minocycline are all semi-synthetic derivatives. The tetracyclines are closely congeneric derivatives of the polycyclic napthacenecarboxamide. The tetracyclines possess a wide range of antimicrobial activity against gram-positive and gram-negative bacteria. In vitro, these drugs are primarily bacteriostatic. Tetracyclines have been used extensively as antimicrobial agents for the treatment of various types of periodontal diseases until light was shed on their equally important non-antimicrobial properties by Golub. The tetracyclines and their non-antimicrobial, chemically modified analogues have properties that appear to modulate host response by inhibiting the activity of the matrix metalloproteinases that cause collagen destruction. They also inhibit osteoclast function, stimulate osteoblastic bone formation, and regulate angiogenesis.


Assuntos
Antibacterianos , Inibidores de Metaloproteinases de Matriz , Antibacterianos/farmacologia , Humanos , Neovascularização Fisiológica , Osteoclastos/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Periodontite/tratamento farmacológico , Tetraciclinas
8.
West Indian med. j ; 50(2): 105-108, Jun. 2001.
Artigo em Inglês | LILACS | ID: lil-333400

RESUMO

The tetracyclines are a group of broad-spectrum antimicrobial agents. The first of these compounds, chlortetracycline was isolated from Streptomyces aureofaciens by Benjamin Duggar and introduced into the market in 1948. In 1952, tetracycline was derived semisynthetically from chlortetracycline by removal of its chlorine atom by catalytic hydrogenation. Methacycline, doxycycline and minocycline are all semi-synthetic derivatives. The tetracyclines are closely congeneric derivatives of the polycyclic napthacenecarboxamide. The tetracyclines possess a wide range of antimicrobial activity against gram-positive and gram-negative bacteria. In vitro, these drugs are primarily bacteriostatic. Tetracyclines have been used extensively as antimicrobial agents for the treatment of various types of periodontal diseases until light was shed on their equally important non-antimicrobial properties by Golub. The tetracyclines and their non-antimicrobial, chemically modified analogues have properties that appear to modulate host response by inhibiting the activity of the matrix metalloproteinases that cause collagen destruction. They also inhibit osteoclast function, stimulate osteoblastic bone formation, and regulate angiogenesis.


Assuntos
Humanos , Tetraciclinas , Metaloproteinases da Matriz , Osteoclastos , Periodontite , Tetraciclinas , Neovascularização Fisiológica , Osteogênese/efeitos dos fármacos
9.
West Indian med. j ; 50(2): 105-8, Jun. 2001.
Artigo em Inglês | MedCarib | ID: med-351

RESUMO

The tetracyclines are a group of broad-spectrum antimicrobial agents. The first of these compounds, chlortetracycline was isolated from Streptomyces aureofaciens by Benjamin Duggar and introduced into the market in 1948. In 1952, tetracycline was derived semisynthetically from chlortetracycline by removal of its chlorine atom by catalytic hydrogenation. Methacycline, doxycycline and minocycline are all semi-synthetic derivatives. The tetracyclines are closely congeneric derivatives of polycyclic napthacenecarboxamide. The tetracyclines posses a wide range of antimicrobial activity against gram-positive and gram-negative bacteria. In vitro, these drugs are primarily bacteriostatic. Tetracycline have been used extensively as antimicrobial, chemically modified non-antimicrobial properties by Golub. The tetracyclines and their non-antimicrobial, chemically modified analogues have properties that appear to modulate host response by inhibiting the activity of the matrix metalloproteinases that cause collagen destruction. They also inhibit osteoclast function, stimulate osteoblastic bone formation, and regulate angiogenesis.(Au)


Assuntos
Técnicas In Vitro , Humanos , Tetraciclinas/farmacologia , Resistência Microbiana a Medicamentos , Doenças Periodontais/tratamento farmacológico , Metaloproteinase 3 da Matriz/antagonistas & inibidores , /farmacologia , Neovascularização Fisiológica , Osteoclastos/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Periodontite/tratamento farmacológico
10.
Indian J Dent Res ; 9(1): 19-22, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-10530188

RESUMO

Bacterial pseudomycosis also known as Botryomycosis is a rare, indolent infection that has been described in patients with immunodeficiency and tissue with decreased healing ability. It affects the visceral organs and infection in the head and neck has been described as affecting the tongue and jaw bones. Histologically, the disease is characterized by the presence of 'Bollinger granules', surrounded by neutrophils in a fibrocellular stroma. A case of gingival Botryomycosis is presented which was diagnosed as a routine pyogenic granuloma in a healthy male.


Assuntos
Doenças da Gengiva/diagnóstico , Granuloma Periapical/diagnóstico , Infecções Estafilocócicas/diagnóstico , Diagnóstico Diferencial , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...